Optometry Advisor3h
Color Vision Test Correlates With Retinal Dystrophy Markers
A color vision test shows good correlation with cone and cone-rod dystrophy biomarkers and may offer a cost-effective replacement for ERG.
News-Medical.Net4h
Research highlights gender and age differences in eye gene therapy responses
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.
Physician's Weekly8h
Genetic and Clinical Factors Influencing HDL and AMD Risk in a Multivariable Model
The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...
The Quad-City Times1d
Eye Surgeons Associates: The macula matters: What you need to know about age-related macular degeneration (AMD)
Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...
Regeneron : EYLEA HD Shows Sustained Vision Gains In Wet AMD Patients At 3 Years
Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) results for EYLEA HD (aflibercept) Injection 8 mg in ...
KWQC on MSN2d
What you need to know about a leading cause of blindness in those 60 and older
AMD is one of the leading causes of blindness in those 60 and older. The disease impairs central vision and limits a person’s ...
Managed Healthcare Executive5d
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...
Roche's Susvimo gets FDA approval for diabetic macular edema
Genentech unit has received FDA approval for its drug Susvimo 100 mg/mL injection for the treatment of diabetic macular edema, a leading cause of blindness for people with diabetes. Susvimo, also ...